BSE Live
Apr 13, 16:01Prev. Close
734.55
Open Price
709.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Apr 13, 15:44Prev. Close
732.00
Open Price
704.00
Bid Price (Qty.)
719.25 (14)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Albert David (in Rs. Cr.) | Mar 05 | Mar 04 | |
| Per Share Ratios | |||
| Basic EPS (Rs.) | 7.37 | 12.71 | |
| Diluted EPS (Rs.) | 7.37 | 12.71 | |
| Cash EPS (Rs.) | 14.27 | 18.81 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 52.79 | 47.71 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 52.79 | 47.71 | |
| Dividend / Share(Rs.) | 2.00 | 2.00 | |
| Revenue from Operations/Share (Rs.) | 179.96 | 202.77 | |
| PBDIT/Share (Rs.) | 20.90 | 27.55 | |
| PBIT/Share (Rs.) | 14.02 | 21.47 | |
| PBT/Share (Rs.) | 11.61 | 19.17 | |
| Net Profit/Share (Rs.) | 7.37 | 12.71 | |
| Profitability Ratios | |||
| PBDIT Margin (%) | 11.61 | 13.58 | |
| PBIT Margin (%) | 7.79 | 10.58 | |
| PBT Margin (%) | 6.45 | 9.45 | |
| Net Profit Margin (%) | 4.09 | 6.26 | |
| Return on Networth / Equity (%) | 13.95 | 26.64 | |
| Return on Capital Employed (%) | 11.86 | 22.62 | |
| Return on Assets (%) | 5.31 | 10.41 | |
| Total Debt/Equity (X) | 0.82 | 0.69 | |
| Asset Turnover Ratio (%) | 129.73 | 166.16 | |
| Liquidity Ratios | |||
| Current Ratio (X) | 1.39 | 1.43 | |
| Quick Ratio (X) | 0.80 | 0.92 | |
| Inventory Turnover Ratio (X) | 4.00 | 6.00 | |
| Dividend Payout Ratio (NP) (%) | 27.14 | 15.73 | |
| Dividend Payout Ratio (CP) (%) | 14.01 | 10.63 | |
| Earnings Retention Ratio (%) | 72.86 | 84.27 | |
| Cash Earnings Retention Ratio (%) | 85.99 | 89.37 | |
| Valuation Ratios | |||
| Enterprise Value (Cr.) | 58.42 | 39.66 | |
| EV/Net Operating Revenue (X) | 0.57 | 0.34 | |
| EV/EBITDA (X) | 4.90 | 2.52 | |
| MarketCap/Net Operating Revenue (X) | 0.50 | 0.29 | |
| Retention Ratios (%) | 72.85 | 84.26 | |
| Price/BV (X) | 1.70 | 1.23 | |
| Price/Net Operating Revenue | 0.50 | 0.29 | |
| Earnings Yield | 0.08 | 0.22 |
25.02.2026
Albert David Standalone December 2025 Net Sales at Rs 89.93 crore, up 8.24% Y-o-Y
13.11.2025
Albert David Standalone September 2025 Net Sales at Rs 87.24 crore, down 11.37% Y-o-Y
05.08.2025
Albert David Standalone June 2025 Net Sales at Rs 70.57 crore, down 21.03% Y-o-Y
13.05.2025
Albert David Standalone March 2025 Net Sales at Rs 74.89 crore, down 15.9% Y-o-Y
25.02.2026
Albert David Standalone December 2025 Net Sales at Rs 89.93 crore, up 8.24% Y-o-Y
13.11.2025
Albert David Standalone September 2025 Net Sales at Rs 87.24 crore, down 11.37% Y-o-Y
05.08.2025
Albert David Standalone June 2025 Net Sales at Rs 70.57 crore, down 21.03% Y-o-Y
13.05.2025
Albert David Standalone March 2025 Net Sales at Rs 74.89 crore, down 15.9% Y-o-Y
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth